What is Aptose Biosciences Inc.’s 1-month forecast?

Meyka AI projects APS.TO could trade near $2.92 in the next month, a move of 22.69% compared to today’s price.

What is Aptose Biosciences Inc.’s 1-year forecast?

By 2027, APS.TO is forecasted to reach $1.36, reflecting a -42.96% change from the current level.

What is Aptose Biosciences Inc.’s 5-year forecast?

The 2030 projection for APS.TO is $4.90, which represents a potential 105.95% change.

What is the 7-year outlook for Aptose Biosciences Inc.?

Over the next 7 years, APS.TO could trade around $6.52, showing a 173.93% move from today’s price.

Can Aptose Biosciences Inc. (APS.TO) reach $7.4 by 2030?

Meyka AI’s 2030 forecast places APS.TO at $4.90, making it unlikely to reach $7.4 by 2030 under current market conditions.

Aptose Biosciences Inc.

APS.TO•TSX

Healthcare

Biotechnology

$2.38

$0.05(2.15%)

Canadian Market opens in 17h 26m

Aptose Biosciences Inc. (APS.TO) Stock Forecast & Price Predictions

Get the latest Aptose Biosciences Inc. (APS.TO) stock forecast across short-term and long-term horizons. Meyka AI generates price predictions using advanced models trained on historical data. These forecasts are not investment advice but directional insights to help investors and traders plan strategies.

Model Information

The Forecast Prediction Model is provided for informational purposes only and should not be considered financial advice. We are continously improving this model to increase accuracy and performance.Read our Full Disclaimer

Monthly Forecast

Predicted Price$2.92

Change↑ $0.54 (22.69%)

Quarterly Forecast

Predicted Price$4.26

Change↑ $1.88 (78.99%)

Yearly Forecast

Predicted Price$1.36

Change↓ $-1.02 (-42.96%)

3 Years Forecast

Predicted Price$3.20

Change↑ $0.82 (34.59%)

5 Years Forecast

Predicted Price$4.90

Change↑ $2.52 (105.95%)

7 Years Forecast

Predicted Price$6.52

Change↑ $4.14 (173.93%)

Aptose Biosciences Inc. Stock Forecast Summary

Aptose Biosciences Inc. (APS.TO) stock is currently priced at $2.38. Based on Meyka AI predictions, the short-term outlook is bullish, with momentum pointing higher. The 1-month projection suggests a move toward $2.92.

In the long term, APS.TO shows a bearish trend. The 2027 forecast points to $1.36 (-42.96% change), while the 2031 forecast suggests $4.90 (105.95% change). Looking 7 years ahead, projections estimate the stock could trade near $6.52, a 173.93% change from today’s price.

Overall Sentiment

Neutral

Short-Term Outlook

Bullish

Long-Term Outlook

Bearish

This mix indicates that Aptose Biosciences Inc. stock is expected to face downside risk over the coming years.

Aptose Biosciences Inc. yearly Price Forecast Chart

Explore the yearly forecast chart for APS.TO, which maps expected price movement, support levels, and resistance targets. The dropdown lets you view forecasts across multiple horizons, from short-term daily trends to 7-year projections, helping investors evaluate Aptose Biosciences Inc. over different timeframes.

No forecast data available

No prediction data found for this time period.

Forecasting data is not available for APS.TOForecasting details for APS.TO are currently unavailable. We're actively monitoring for updates and will publish them as soon as they’re released. Please check back again shortly.

Aptose Biosciences Inc. Stock Forecast 2026

The forecast for Aptose Biosciences Inc. (APS.TO) in 2026 suggests a price of $1.36, representing a -42.96% move from today’s price.

Average Target: $1.36

Market Outlook: bearish based on current trend indicators.

Key Drivers in 2026:

Earnings growth projections.
Competitive performance in the Healthcare.
Macroeconomic factors such as interest rates and inflation.

Aptose Biosciences Inc. Stock Forecast 2030

By 2030, Meyka AI projects APS.TO could trade near $4.90, showing a potential 105.95% compared to current levels.

Average Target: $4.90

Market Outlook: bullish.

What could influence the 2030 forecast:

Technological innovation and product cycles.
Expansion into global markets.
Long-term investor sentiment toward Aptose Biosciences Inc..

Aptose Biosciences Inc. 7-Year Stock Forecast (2032–2033)

Looking 7 years ahead, the long-term forecast for APS.TO points to a price around $6.52, which is a projected 173.93% move from today’s level.

Average Target: $6.52

Outlook: bullish, depending on macroeconomic conditions and sector growth.

Long-Term Drivers:

Global economic expansion or contraction.
Regulatory and policy environment.
Aptose Biosciences Inc.’s ability to maintain market leadership.